LCO \\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-R01-
HB.docx
1 of 16
General Assembly Substitute Bill No. 5147
February Session, 2022
AN ACT CONCERNING PHYSICIAN ASSISTANTS AND THE
PALLIATIVE USE OF MARIJUANA.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
Section 1. Section 21a-408 of the 2022 supplement to the general 1
statutes is repealed and the following is substituted in lieu thereof 2
(Effective January 1, 2023): 3
As used in this section, sections 21a-408a to 21a-408o, inclusive, as 4
amended by this act, and sections 21a-408r to 21a-408v, inclusive, unless 5
the context otherwise requires: 6
(1) "Advanced practice registered nurse" means an advanced practice 7
registered nurse licensed pursuant to chapter 378; 8
(2) "Cannabis establishment" has the same meaning as provided in 9
section 21a-420; 10
(3) "Cultivation" includes planting, propagating, cultivating, growing 11
and harvesting; 12
(4) "Debilitating medical condition" means (A) cancer, glaucoma, 13
positive status for human immunodeficiency virus or acquired immune 14
deficiency syndrome, Parkinson's disease, multiple sclerosis, damage to 15
the nervous tissue of the spinal cord with objective neurological 16 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
2 of 16
indication of intractable spasticity, epilepsy or uncontrolled intractable 17
seizure disorder, cachexia, wasting syndrome, Crohn's disease, 18
posttraumatic stress disorder, irreversible spinal cord injury with 19
objective neurological indication of intractable spasticity, cerebral palsy, 20
cystic fibrosis or terminal illness requiring end-of-life care, except, if the 21
qualifying patient is under eighteen years of age, "debilitating medical 22
condition" means terminal illness requiring end-of-life care, irreversible 23
spinal cord injury with objective neurological indication of intractable 24
spasticity, cerebral palsy, cystic fibrosis, severe epilepsy or uncontrolled 25
intractable seizure disorder, or (B) any medical condition, medical 26
treatment or disease approved for qualifying patients by the 27
Department of Consumer Protection and posted online pursuant to 28
section 21a-408l; 29
(5) "Dispensary facility" means a place of business where marijuana 30
may be dispensed, sold or distributed in accordance with this chapter 31
and any regulations adopted thereunder to qualifying patients and 32
caregivers and for which the department has issued a dispensary facility 33
license pursuant to this chapter; 34
(6) "Employee" has the same meaning as provided in section 21a-420; 35
(7) "Institutional animal care and use committee" means a committee 36
that oversees an organization's animal program, facilities and 37
procedures to ensure compliance with federal policies, guidelines and 38
principles related to the care and use of animals in research; 39
(8) "Institutional review board" means a specifically constituted 40
review body established or designated by an organization to protect the 41
rights and welfare of persons recruited to participate in biomedical, 42
behavioral or social science research; 43
(9) "Laboratory" means a laboratory located in the state that is 44
licensed by the department to provide analysis of marijuana and that 45
meets the licensure requirements set forth in section 21a-246, as 46
amended by this act; 47 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
3 of 16
(10) "Laboratory employee" means a person who is registered as a 48
laboratory employee pursuant to section 21a-408r; 49
(11) "Licensed dispensary" or "dispensary" means an individual who 50
is a licensed pharmacist employed by a dispensary facility or hybrid 51
retailer; 52
(12) "Producer" means a person who is licensed as a producer 53
pursuant to section 21a-408i; 54
(13) "Marijuana" means marijuana, as defined in section 21a-240; 55
(14) "Nurse" means a person who is licensed as a nurse under chapter 56
378; 57
(15) "Palliative use" means the acquisition, distribution, transfer, 58
possession, use or transportation of marijuana or paraphernalia relating 59
to marijuana, including the transfer of marijuana and paraphernalia 60
relating to marijuana from the patient's caregiver to the qualifying 61
patient, to alleviate a qualifying patient's symptoms of a debilitating 62
medical condition or the effects of such symptoms, but does not include 63
any such use of marijuana by any person other than the qualifying 64
patient; 65
(16) "Paraphernalia" means drug paraphernalia, as defined in section 66
21a-240; 67
(17) "Physician" means a person who is licensed as a physician under 68
chapter 370; [, but does not include a physician assistant, as defined in 69
section 20-12a;] 70
(18) "Physician assistant" means a person who is licensed as a 71
physician assistant under chapter 370; 72
[(18)] (19) "Caregiver" means a person, other than the qualifying 73
patient and the qualifying patient's physician, physician assistant or 74
advanced practice registered nurse, who is eighteen years of age or older 75 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
4 of 16
and has agreed to undertake responsibility for managing the well-being 76
of the qualifying patient with respect to the palliative use of marijuana, 77
provided (A) in the case of a qualifying patient (i) under eighteen years 78
of age and not an emancipated minor, or (ii) otherwise lacking legal 79
capacity, such person shall be a parent, guardian or person having legal 80
custody of such qualifying patient, and (B) in the case of a qualifying 81
patient eighteen years of age or older or an emancipated minor, the need 82
for such person shall be evaluated by the qualifying patient's physician, 83
physician assistant or advanced practice registered nurse and such need 84
shall be documented in the written certification; 85
[(19)] (20) "Qualifying patient" means a person who: (A) Is a resident 86
of Connecticut, (B) has been diagnosed by a physician, physician 87
assistant or [an] advanced practice registered nurse as having a 88
debilitating medical condition, and (C) (i) is eighteen years of age or 89
older, (ii) is an emancipated minor, or (iii) has written consent from a 90
custodial parent, guardian or other person having legal custody of such 91
person that indicates that such person has permission from such parent, 92
guardian or other person for the palliative use of marijuana for a 93
debilitating medical condition and that such parent, guardian or other 94
person will (I) serve as a caregiver for the qualifying patient, and (II) 95
control the acquisition and possession of marijuana and any related 96
paraphernalia for palliative use on behalf of such person. "Qualifying 97
patient" does not include an inmate confined in a correctional institution 98
or facility under the supervision of the Department of Correction; 99
[(20)] (21) "Research program" means a study approved by the 100
Department of Consumer Protection in accordance with this chapter 101
and undertaken to increase information or knowledge regarding the 102
growth or processing of marijuana, or the medical attributes, dosage 103
forms, administration or use of marijuana to treat or alleviate symptoms 104
of any medical conditions or the effects of such symptoms; 105
[(21)] (22) "Research program employee" means a person who (A) is 106
registered as a research program employee under section 21a-408t, or 107
(B) holds a temporary certificate of registration issued pursuant to 108 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
5 of 16
section 21a-408t; 109
[(22)] (23) "Research program subject" means a person registered as a 110
research program subject pursuant to section 21a-408v; 111
[(23)] (24) "Usable marijuana" means the dried leaves and flowers of 112
the marijuana plant, and any mixtures or preparations of such leaves 113
and flowers, that are appropriate for the palliative use of marijuana, but 114
does not include the seeds, stalks and roots of the marijuana plant; and 115
[(24)] (25) "Written certification" means a written certification issued 116
by a physician, physician assistant or [an] advanced practice registered 117
nurse pursuant to section 21a-408c, as amended by this act. 118
Sec. 2. Section 21a-408a of the 2022 supplement to the general statutes 119
is repealed and the following is substituted in lieu thereof (Effective 120
January 1, 2023): 121
(a) A qualifying patient shall register with the Department of 122
Consumer Protection pursuant to section 21a-408d, as amended by this 123
act, prior to engaging in the palliative use of marijuana. A qualifying 124
patient who has a valid registration certificate from the Department of 125
Consumer Protection pursuant to subsection (a) of section 21a-408d, as 126
amended by this act, and complies with the requirements of sections 127
21a-408 to 21a-408m, as amended by this act, inclusive, shall not be 128
subject to arrest or prosecution, penalized in any manner, including, but 129
not limited to, being subject to any civil penalty, or denied any right or 130
privilege, including, but not limited to, being subject to any disciplinary 131
action by a professional licensing board, for the palliative use of 132
marijuana if: 133
(1) The qualifying patient's physician, physician assistant or 134
advanced practice registered nurse has issued a written certification to 135
the qualifying patient for the palliative use of marijuana after the 136
physician, physician assistant or advanced practice registered nurse has 137
prescribed, or determined it is not in the best interest of the patient to 138
prescribe, prescription drugs to address the symptoms or effects for 139 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
6 of 16
which the certification is being issued; 140
(2) The combined amount of marijuana possessed by the qualifying 141
patient and the caregiver for palliative use does not exceed five ounces; 142
(3) The qualifying patient has not more than one caregiver at any 143
time; and 144
(4) Any cannabis plants grown by the qualifying patient in his or 145
home is in compliance with subsection (b) of section 21a-408d, as 146
amended by this act, and any applicable regulations. 147
(b) The provisions of subsection (a) of this section do not apply to: 148
(1) Any palliative use of marijuana that endangers the health or well-149
being of a person other than the qualifying patient or the caregiver; or 150
(2) The ingestion of marijuana (A) in a motor bus or a school bus or 151
in any other moving vehicle, (B) in the workplace, (C) on any school 152
grounds or any public or private school, dormitory, college or university 153
property, unless such college or university is participating in a research 154
program and such use is pursuant to the terms of the research program, 155
(D) in any public place, or (E) in the presence of a person under the age 156
of eighteen, unless such person is a qualifying patient or research 157
program subject. For the purposes of this subdivision, (i) "presence" 158
means within the direct line of sight of the palliative use of marijuana or 159
exposure to second-hand marijuana smoke, or both; (ii) "public place" 160
means any area that is used or held out for use by the public whether 161
owned or operated by public or private interests; (iii) "vehicle" means a 162
vehicle, as defined in section 14-1; (iv) "motor bus" means a motor bus, 163
as defined in section 14-1; and (v) "school bus" means a school bus, as 164
defined in section 14-1. 165
Sec. 3. Section 21a-408c of the 2022 supplement to the general statutes 166
is repealed and the following is substituted in lieu thereof (Effective 167
January 1, 2023): 168 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
7 of 16
(a) A physician, physician assistant or [an] advanced practice 169
registered nurse may issue a written certification to a qualifying patient 170
that authorizes the palliative use of marijuana by the qualifying patient. 171
Such written certification shall be in the form prescribed by the 172
Department of Consumer Protection and shall include a statement 173
signed and dated by the qualifying patient's physician, physician 174
assistant or advanced practice registered nurse stating that, in such 175
physician's, physician assistant's or advanced practice registered nurse's 176
professional opinion, the qualifying patient has a debilitating medical 177
condition and the potential benefits of the palliative use of marijuana 178
would likely outweigh the health risks of such use to the qualifying 179
patient. 180
(b) Any written certification for the palliative use of marijuana issued 181
by a physician, physician assistant or [an] advanced practice registered 182
nurse under subsection (a) of this section shall be valid for a period not 183
to exceed one year from the date such written certification is signed and 184
dated by the physician, physician assistant or advanced practice 185
registered nurse. Not later than ten calendar days after the expiration of 186
such period, or at any time before the expiration of such period should 187
the qualifying patient no longer wish to possess marijuana for palliative 188
use, the qualifying patient or the caregiver shall destroy all usable 189
marijuana possessed by the qualifying patient and the caregiver for 190
palliative use. 191
(c) A physician, physician assistant or [an] advanced practice 192
registered nurse shall not be subject to arrest or prosecution, penalized 193
in any manner, including, but not limited to, being subject to any civil 194
penalty, or denied any right or privilege, including, but not limited to, 195
being subject to any disciplinary action by the Connecticut Medical 196
Examining Board, the Connecticut State Board of Examiners for Nursing 197
or other professional licensing board, for providing a written 198
certification for the palliative use of marijuana under subdivision (1) of 199
subsection (a) of section 21a-408a, as amended by this act, if: 200
(1) The physician, physician assistant or advanced practice registered 201 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
8 of 16
nurse has diagnosed the qualifying patient as having a debilitating 202
medical condition; 203
(2) The physician, physician assistant or advanced practice registered 204
nurse has explained the potential risks and benefits of the palliative use 205
of marijuana to the qualifying patient and, if the qualifying patient lacks 206
legal capacity, to a parent, guardian or person having legal custody of 207
the qualifying patient; 208
(3) The written certification issued by the physician, physician 209
assistant or advanced practice registered nurse is based upon the 210
physician's, physician assistant's or advanced practice registered nurse's 211
professional opinion after having completed a medically reasonable 212
assessment of the qualifying patient's medical history and current 213
medical condition made in the course of a bona fide health care 214
professional-patient relationship; and 215
(4) The physician, physician assistant or advanced practice registered 216
nurse has no financial interest in a cannabis establishment, except for 217
retailers and delivery services, as such terms are defined in section 21a-218
420. 219
(d) A physician assistant or nurse shall not be subject to arrest or 220
prosecution, penalized in any manner, including, but not limited to, 221
being subject to any civil penalty, or denied any right or privilege, 222
including, but not limited to, being subject to any disciplinary action by 223
the Connecticut Medical Examining Board, Board of Examiners for 224
Nursing [,] or other professional licensing board, for administering 225
marijuana to a qualifying patient or research program subject in a 226
hospital or health care facility licensed by the Department of Public 227
Health. 228
(e) Notwithstanding the provisions of this section, sections 21a-408 to 229
21a-408b, inclusive, as amended by this act, and sections 21a-408d to 230
21a-408o, inclusive, as amended by this act, a physician assistant or an 231
advanced practice registered nurse shall not issue a written certification 232 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
9 of 16
to a qualifying patient when the qualifying patient's debilitating medical 233
condition is glaucoma. 234
Sec. 4. Section 21a-408d of the 2022 supplement to the general statutes 235
is repealed and the following is substituted in lieu thereof (Effective 236
January 1, 2023): 237
(a) Each qualifying patient who is issued a written certification for the 238
palliative use of marijuana under subdivision (1) of subsection (a) of 239
section 21a-408a, as amended by this act, and the caregiver of such 240
qualifying patient, shall register with the Department of Consumer 241
Protection. Such registration shall be effective from the date the 242
Department of Consumer Protection issues a certificate of registration 243
until the expiration of the written certification issued by the physician, 244
physician assistant or advanced practice registered nurse. The 245
qualifying patient and the caregiver shall provide sufficient identifying 246
information, as determined by the department, to establish the personal 247
identity of the qualifying patient and the caregiver. If the qualifying 248
patient is under eighteen years of age and not an emancipated minor, 249
the custodial parent, guardian or other person having legal custody of 250
the qualifying patient shall also provide a letter from both the qualifying 251
patient's care provider and a physician who is board certified in an area 252
of medicine involved in the treatment of the debilitating condition for 253
which the qualifying patient was certified that confirms that the 254
palliative use of marijuana is in the best interest of the qualifying 255
patient. A physician may issue a written certification for the palliative 256
use of marijuana by a qualifying patient who is under eighteen years of 257
age, provided such written certification shall not be for marijuana in a 258
dosage form that requires that the marijuana be smoked, inhaled or 259
vaporized. The qualifying patient or the caregiver shall report any 260
change in the identifying information to the department not later than 261
five business days after such change. The department shall issue a 262
registration certificate to the qualifying patient and to the caregiver and 263
may charge a reasonable fee, not to exceed twenty-five dollars, for each 264
registration certificate issued under this subsection. Any registration 265 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
10 of 16
fees collected by the department under this subsection shall be paid to 266
the State Treasurer and credited to the General Fund. 267
(b) Any qualifying patient who is eighteen years of age or older may 268
cultivate up to three mature cannabis plants and three immature 269
cannabis plants in the patient's primary residence at any given time, 270
provided such plants are secure from access by any individual other 271
than the patient or patient's caregiver and no more than twelve cannabis 272
plants may be grown per household. 273
(c) A dispensary shall not dispense any marijuana products in a 274
smokable, inhalable or vaporizable form to a qualifying patient who is 275
under eighteen years of age or such qualifying patient's caregiver. 276
(d) Information obtained under this section shall be confidential and 277
shall not be subject to disclosure under the Freedom of Information Act, 278
as defined in section 1-200, except that reasonable access to registry 279
information obtained under this section shall be provided to: (1) State 280
agencies, federal agencies and local law enforcement agencies for the 281
purpose of investigating or prosecuting a violation of law; (2) 282
physicians, physician assistants, advanced practice registered nurses 283
and pharmacists for the purpose of providing patient care and drug 284
therapy management and monitoring controlled substances obtained by 285
the qualifying patient; (3) public or private entities for research or 286
educational purposes, provided no individually identifiable health 287
information may be disclosed; (4) a licensed dispensary for the purpose 288
of complying with sections 21a-408 to 21a-408m, inclusive, as amended 289
by this act; (5) a qualifying patient, but only with respect to information 290
related to such qualifying patient or such qualifying patient's caregiver; 291
or (6) a caregiver, but only with respect to information related to such 292
caregiver's qualifying patient. 293
Sec. 5. Section 21a-408m of the 2022 supplement to the general 294
statutes is repealed and the following is substituted in lieu thereof 295
(Effective January 1, 2023): 296 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
11 of 16
(a) The Commissioner of Consumer Protection may adopt 297
regulations, in accordance with chapter 54, to establish (1) a standard 298
form for written certifications for the palliative use of marijuana issued 299
by physicians, physician assistants and advanced practice registered 300
nurses under subdivision (1) of subsection (a) of section 21a-408a, as 301
amended by this act, and (2) procedures for registrations under section 302
21a-408d, as amended by this act. Such regulations, if any, shall be 303
adopted after consultation with the Board of Physicians established in 304
section 21a-408l. 305
(b) The Commissioner of Consumer Protection shall adopt 306
regulations, in accordance with chapter 54, to establish a reasonable fee 307
to be collected from each qualifying patient to whom a written 308
certification for the palliative use of marijuana is issued under 309
subdivision (1) of subsection (a) of section 21a-408a, as amended by this 310
act, for the purpose of offsetting the direct and indirect costs of 311
administering the provisions of sections 21a-408 to 21a-408m, inclusive, 312
as amended by this act. The commissioner shall collect such fee at the 313
time the qualifying patient registers with the Department of Consumer 314
Protection under subsection (a) of section 21a-408d, as amended by this 315
act. Such fee shall be in addition to any registration fee that may be 316
charged under said subsection. The fees required to be collected by the 317
commissioner from qualifying patients under this subsection shall be 318
paid to the State Treasurer and credited to the General Fund. 319
(c) The Commissioner of Consumer Protection shall adopt or amend 320
regulations, as applicable, in accordance with chapter 54, to implement 321
the provisions of sections 21a-408 to 21a-408g, inclusive, as amended by 322
this act, and section 21a-408l. Notwithstanding the requirements of 323
sections 4-168 to 4-172, inclusive, in order to effectuate the purposes of 324
sections 21a-408 to 21a-408g, inclusive, as amended by this act, and 325
section 21a-408l, and protect public health and safety, prior to adopting 326
or amending such regulations the commissioner shall adopt policies and 327
procedures to implement the provisions of sections 21a-408 to 21a-408g, 328
inclusive, as amended by this act, and section 21a-408, as amended by 329 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
12 of 16
this act, that shall have the force and effect of law. The commissioner 330
shall post all policies and procedures on the department's Internet web 331
site, and submit such policies and procedures to the Secretary of the 332
State for posting on the eRegulations System, at least fifteen days prior 333
to the effective date of any policy or procedure. Any such policy or 334
procedure shall no longer be effective upon the earlier of either adoption 335
of such policies or procedures as a final regulation pursuant to section 336
4-172 or forty-eight months from October 1, 2021, if such policies or 337
procedures have not been submitted to the legislative regulation review 338
committee for consideration under section 4-170. Such policies and 339
procedures and regulations shall include, but not be limited to, how the 340
department shall: 341
(1) Accept applications for the issuance and renewal of registration 342
certificates for qualifying patients and caregivers; 343
(2) Establish criteria for adding medical conditions, medical 344
treatments or diseases to the list of debilitating medical conditions that 345
qualify for the palliative use of marijuana; 346
(3) Establish a petition process under which members of the public 347
may submit petitions, regarding the addition of medical conditions, 348
medical treatments or diseases to the list of debilitating medical 349
conditions; 350
(4) Establish requirements for the growing of cannabis plants by a 351
qualifying patient in his or her primary residence as authorized under 352
section 21a-408d, as amended by this act, including requirements for 353
securing such plants to prevent access by any individual other than the 354
patient or the patient's caregiver, the location of such plants and any 355
other requirements necessary to protect public health or safety; 356
(5) Develop a distribution system for marijuana for palliative use that 357
provides for: 358
(A) Marijuana production facilities within this state that are housed 359
on secured grounds and operated by producers; 360 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
13 of 16
(B) The transfer of marijuana between dispensary facilities; and 361
(C) Distribution of marijuana for palliative use to qualifying patients 362
or their caregivers by dispensary facilities, hybrid retailers and delivery 363
services, as such terms are defined in section 21a-420; and 364
(6) Ensure an adequate supply and variety of marijuana to dispensary 365
facilities and hybrid retailers to ensure uninterrupted availability for 366
qualifying patients, based on historical marijuana purchase patterns by 367
qualifying patients. 368
Sec. 6. Subsection (a) of section 21a-246 of the general statutes is 369
repealed and the following is substituted in lieu thereof (Effective January 370
1, 2023): 371
(a) No person within this state shall manufacture, wholesale, 372
repackage, supply, compound, mix, cultivate or grow, or by other 373
process produce or prepare, controlled substances without first 374
obtaining a license to do so from the Commissioner of Consumer 375
Protection and no person within this state shall operate a laboratory for 376
the purpose of research or analysis using controlled substances without 377
first obtaining a license to do so from the Commissioner of Consumer 378
Protection, except that such activities by pharmacists or pharmacies in 379
the filling and dispensing of prescriptions or activities incident thereto, 380
or the dispensing or administering of controlled substances by dentists, 381
podiatrists, physicians, physician assistants, advanced practice 382
registered nurses or veterinarians, or other persons acting under their 383
supervision, in the treatment of patients shall not be subject to the 384
provisions of this section, and provided laboratories for instruction in 385
dentistry, medicine, nursing, pharmacy, pharmacology and 386
pharmacognosy in institutions duly licensed for such purposes in this 387
state shall not be subject to the provisions of this section except with 388
respect to narcotic drugs and schedule I and II controlled substances. 389
Upon application of any physician or physician assistant licensed 390
pursuant to chapter 370, or an advanced practice registered nurse 391
licensed pursuant to chapter 378, the Commissioner of Consumer 392 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
14 of 16
Protection shall without unnecessary delay, (1) license such physician to 393
possess and supply marijuana for the treatment of glaucoma or the side 394
effects of chemotherapy, or (2) license such physician assistant or 395
advanced practice registered nurse to possess and supply marijuana for 396
the treatment of the side effects of chemotherapy. No person outside this 397
state shall sell or supply controlled substances within this state without 398
first obtaining a license to do so from the Commissioner of Consumer 399
Protection, provided no such license shall be required of a manufacturer 400
whose principal place of business is located outside this state and who 401
is registered with the federal Drug Enforcement Administration or other 402
federal agency, and who files a copy of such registration with the 403
appropriate licensing authority under this chapter. 404
Sec. 7. Section 21a-253 of the general statutes is repealed and the 405
following is substituted in lieu thereof (Effective January 1, 2023): 406
Any person may possess or have under his control a quantity of 407
marijuana less than or equal to that quantity supplied to him pursuant 408
to a prescription made in accordance with the provisions of section 21a-409
249 by (1) a physician licensed under the provisions of chapter 370 and 410
further authorized by subsection (a) of section 21a-246, as amended by 411
this act, by the Commissioner of Consumer Protection to possess and 412
supply marijuana for the treatment of glaucoma or the side effects of 413
chemotherapy, or (2) a physician assistant licensed under the provisions 414
of chapter 370, or an advanced practice registered nurse licensed under 415
the provisions of chapter 378, and further authorized by subsection (a) 416
of section 21a-246, as amended by this act, by said commissioner to 417
possess and supply marijuana for the treatment of the side effects of 418
chemotherapy. 419
Sec. 8. Section 7 of public act 21-9 is repealed and the following is 420
substituted in lieu thereof (Effective January 1, 2023): 421
(a) As used in this section: 422
(1) "Advanced practice registered nurse" means an advanced practice 423 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
15 of 16
registered nurse licensed pursuant to chapter 378 of the general statutes; 424
(2) "Physician" has the same meaning as provided in section 21a-408 425
of the general statutes, as amended by this act; 426
(3) "Physician assistant" has the same meaning as provided in section 427
21a-408 of the general statutes, as amended by this act; 428
[(3)] (4) "Qualifying patient" has the same meaning as provided in 429
section 21a-408 of the general statutes, as amended by this act; and 430
[(4)] (5) "Written certification" has the same meaning as provided in 431
section 21a-408 of the general statutes, as amended by this act. 432
(b) Notwithstanding the provisions of sections 21a-408 to 21a-408n, 433
inclusive, of the general statutes, as amended by this act, or any other 434
section, regulation, rule, policy or procedure concerning the certification 435
of medical marijuana patients, a physician, physician assistant or 436
advanced practice registered nurse may issue a written certification to a 437
qualifying patient and provide any follow-up care using telehealth 438
services during the period beginning on the effective date of this section 439
and ending on June 30, 2023, provided all other requirements for issuing 440
the written certification to the qualifying patient and all recordkeeping 441
requirements are satisfied. 442
This act shall take effect as follows and shall amend the following
sections:
Section 1 January 1, 2023 21a-408
Sec. 2 January 1, 2023 21a-408a
Sec. 3 January 1, 2023 21a-408c
Sec. 4 January 1, 2023 21a-408d
Sec. 5 January 1, 2023 21a-408m
Sec. 6 January 1, 2023 21a-246(a)
Sec. 7 January 1, 2023 21a-253
Sec. 8 January 1, 2023 PA 21-9, Sec. 7 Substitute Bill No. 5147
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05147-
R01-HB.docx }
16 of 16
Statement of Legislative Commissioners:
In Section 6(a)(2), "advanced practice registered nurse or physician
assistant" was changed to "physician assistant or advanced practice
registered nurse" for consistency; and in section 7(2), "an advanced
practice registered nurse licensed under the provisions of chapter 378 or
a physician assistant licensed under the provisions of chapter 370" was
changed to "a physician assistant licensed under the provisions of
chapter 370, or an advanced practice registered nurse licensed under the
provisions of chapter 378," for consistency.
GL Joint Favorable Subst.